Newsfeeds Archive - Page 63 of 167

1 minute read

Acuity Brands Q4 EPS $3.95 Beats $3.58 Estimate, Sales $1.11B Beat $1.08B Estimate

October 4, 6:01 AM

Acuity Brands (NYSE:AYI) reported quarterly earnings of $3.95 per share which beat the analyst consensus estimate of $3.58 by 10.34 percent. This is a 20.8 percent increase over earnings of $3.27 per share from the same

AYI

1 minute read

Federal Reserve

Fed’s Williams Says The Fed’s Rapid Rate Hikes Have Been Very Beneficial

By Bill Haddad

October 3, 4:19 PM

-Reuters

SPY

1 minute read

Amneal Pharmaceuticals Announces Commercial Launch Of ALYMSYS

By Bill Haddad

October 3, 4:09 PM

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) (“Amneal” or the “Company”) today announced the commercial launch of ALYMSYS® (bevacizumab-maly), a biosimilar referencing Avastin®. ALYMSYS®

AMRX

1 minute read

News

Professional Diversity Network, Inc. Announces 9% Equity Investment In Koala Crypto Limited For $1.35M

By Bill Haddad

September 30, 9:05 AM

Professional Diversity Network, Inc. (NASDAQ:IPDN) (“PDN” or “Company”), a developer and operator of online and in-person diversity talent networks that provides access to networking, training,

IPDN

1 minute read

Global
News

US State Dept Says We Are Sharing Information In Our Possession Regarding Apparent Acts Of Sabotage On Russian Gas Pipelines

By Bill Haddad

September 28, 2:40 PM

-Reuters

RSX

1 minute read

US Advance Aug. Wholesale Inventories +1.3%

By Bill Haddad

September 28, 8:31 AM

-Reuters

SPY

1 minute read

MaxCyte Signs Strategic Platform License With Vertex Pharmaceuticals To Advance CRISPR/Cas9-Based Gene-Editing Program

By Bill Haddad

September 28, 8:06 AM

Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell therapy exa-cel, formerly known as CTX001™ for

MXCT

2 minute read

FDA Authorizes An Extension Of The In-Use Period For UroGen Pharma’s JELMYTO Admixture To 96 Hours Following Reconstitution

By Bill Haddad

September 28, 8:04 AM

-- This Extension Increases Flexibility and Efficiency for Customers and Patients -- PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing

URGN

1 minute read

Tech

Valens Semiconductor Collaborates With Intel To Boost Automotive MIPI A-PHY Implementations

By Bill Haddad

September 28, 8:02 AM

HOD HASHARON, Israel, September 28, 2022 /PRNewswire/ -- Valens Semiconductor (NYSE:VLN) today announced a collaboration with Intel to develop MIPI A-PHY-compliant automotive technologies for foundry customers,

INTC

1 minute read